Sun Pharma trading at 783 with downfall by 3.85%
Sun Pharma trading at 783 with downfall by 3.85%.
May 31, 2016, 13:48 PM IST
Sun Pharma fourth quarter profit almost doubles but misses estimates
MUMBAI: India`s largest drugmaker Sun Pharmaceutical Industries Ltd reported a near-doubling in fourth-quarter profit, although that missed analysts` estimates as weakness in emerging markets outweighed higher sales in India and the United States.
May 31, 2016, 12:11 PM IST
Sun Pharma looking to divest Ireland plant
"Decisions are being made to either close or divest some of our manufacturing facilities," a Sun Pharma spokesman said in an emailed statement.
Sep 10, 2015, 08:04 AM IST
Sun-Ranbaxy deal: CCI raises concerns about molecules market
Sun Pharma and Ranbaxy had announced a USD 4-billion deal that would create one of the top five largest speciality generics company in the world.
Aug 29, 2014, 13:51 PM IST
Sun Pharma-Ranbaxy deal comes under CCI scanner
CCI would take a final view on the deal after receiving details from them and could seek more information if it is not satisfied with the responses.
Aug 08, 2014, 12:34 PM IST
Management rejig at Ranbaxy; Arno Gessner replaces Dale Adkisson
Meanwhile the company has made Alexander Gebauer as its new head of global research and development.
Jul 26, 2014, 11:16 AM IST
Ranbaxy gets FDA approval for Novartis' Diovan generic
Ranbaxy will be the first rival drugmaker to launch a copy of Diovan in the United States and will be entitled to six months of exclusivity to sell it.
Jun 27, 2014, 09:39 AM IST
